Drug in Clinical Trials for Breast Cancer Shows Promise for Treating Blood Cancers
Prime Highlights: Washington University research identifies a potential new use for an existing drug. RSK1
Medicare’s $2,000 Cap on Out-of-Pocket Drug Costs Set to Offer Significant Savings AARP Reports
Prime Highlights: Medicare’s new $2,000 cap on out-of-pocket prescription drug costs could save patients thousands.
UnitedHealth Surpasses Profit Expectations in Q4 Driven by Strong Health Services Performance
Prime Highlights: UnitedHealth reports Q4 earnings of $6.81 per share, exceeding estimates of $6.72. Health
Pfizer to Sell $3 Billion Stake in Haleon Reducing Ownership to 7.3%
Prime Highlights: Pfizer to sell $3.05 billion worth of shares in Haleon, reducing its stake
Eli Lilly to Acquire Scorpion Therapeutics’ Cancer Therapy for Up to $2.5 Billion
Prime Highlights: Eli Lilly to acquire Scorpion Therapeutics’ experimental cancer therapy, STX-478, for up to
Telix Pharmaceuticals Acquires ImaginAb for $73 Million to Expand Antibody Engineering Capabilities
Prime Highlights: Telix secures a US$45 million ($73 million) deal to acquire US-based antibody engineering
DBAY Advisors to Acquire Alliance Pharma in $430 Million All-Cash Deal
Prime Highlights: DBAY Advisors, an asset management firm, has agreed to acquire UK-based Alliance Pharma
Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment
Prime Highlights: Medicare will now cover Eli Lilly’s Zepbound for obstructive sleep apnea, following FDA
ACG Opens State-of-the-Art Capsule Manufacturing Facility in Thailand
Prime Highlights: ACG has inaugurated a cutting-edge capsule manufacturing facility in Rayong, Thailand, marking it
Cancer-Preventing Immunotherapy Harnesses Immune System to Combat Pre-cancers, Offering Long-Term Protection
Prime Highlights: Mass General Brigham researchers developed a novel immunotherapy that prevents squamous cell carcinoma
New Migraine Drug Can Start Working in Days, Experts Find
Prime Highlights: Atogepant, appears to begin acting quickly, and the frequency of migraine attacks may
European Commission Approves Rybrevant with Lazcluze for Advanced Lung Cancer Treatment
Prime Highlights: The European Commission has approved the combination of Rybrevant (amivantamab) and Lazcluze (lazertinib)
